Treatment of allergic rhinitis can improve blood pressure control

Journal of Human Hypertension

Volumn 20, Issue 11, 2006, Pages 888-893

  Magen, E ^a   Yosefy, C ^b   Viskoper, R J ^a   Mishal, J ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FEXOFENADINE; FLUTICASONE PROPIONATE; HYDROCHLOROTHIAZIDE; SODIUM CHLORIDE;

ADULT; ALLERGIC RHINITIS; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANALYSIS OF VARIANCE; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX; SODIUM CHLORIDE; TERFENADINE; TREATMENT OUTCOME;

EID: 33750320603     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002088     Document Type: Article

References (37)

1. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European community respiratory health survey (ECRHS). Eur Respir J 1996; 9: 687-695.
2. Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Pressure 2002; 11: 35-45.
3. Shahar E, Lorber M. Prevalence of self-reported allergic conditions in an adult population in Israel. Isr Med Assoc J 2001; 3: 190-193.
4. Ginsberg GM, Tulchinsky TH, Salahov E, Clayman M. Standardized mortality ratios by region of residence, Israel, 1987-1994: A tool for public health policy. Public Health Rev 2003; 31: 111-131.
5. Kony S, Zureik M, Neukirch C, Leynaert B, Vervloet D, Neukirch F. Rhinitis is associated with increased systolic blood pressure in men: A population-based study. Am J Respir Crit Care Med 2003; 167: 538-543.
6. Peppard PE, Young T. Nose and blood pressure. Am J Respir Crit Care Med 2004; 169: 318.
7. Dahl M, Tybjaerg-Hansen A, Nordestgaard BG, Lange P, Vestbo J. Nose and blood pressure. Am J Respir Crit Care Med 2004; 169: 318.
8. Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006; 15: 152-158.
9. Grundy M. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003; 290: 3000-3002.
10. Dorffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR et al. Preactivation peripheral blood monocytes in patients with essential hypertension. Hypertension 1999; 34: 113-117.
11. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens 2002; 20: 593-596.
12. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marches S et al. Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressure. J Hypertens 2003; 21: 1841-1846.
13. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-2951.
14. King DE, Egan BM, Mainous III AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich) 2004; 6: 562-568.
15. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (Creactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 2005; 19: 149-154.
16. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 57: 483-491.
17. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the rhino-conjunctivitis quality of life questionnaire. J Allergy Clin Immunol 1999; 104: 364-369.
18. Chaprin D, Sibbald B, Weeke E, Wuthrich B. Epidemiologic identification of allergic rhinitis. Allergy 1996; 57: 293-298.
19. Amar J, Ruidavets JB, Peyrieux JC, Mallion JM, Ferrieres J, Safar ME et al. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects. Hypertension 2005; 46: 151-155.
20. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24: 969-974.
21. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy II PF et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005; 18: 1123-1129.
22. Borish L. Allergic rhinitis: Systemic inflammation and implications for management. J Allergy Clin Immunol 2003; 112: 1021-1031.
23. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004; 114(Suppl): S135-S138.
24. Lerner D, Levine S. Health related quality of life: Origins, gaps, and directions. Adv Med Sociol 1994; 5: 43-65.
25. Avis N, Smith K. Conceptual and methodological issues in selecting and developing quality of life measures. Adv Med Sociol 1994; 5: 255-280.
26. Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 2004; 24: 344-350.
27. McCraty R, Atkinson M, Tomasino D. Impact of a workplace stress reduction program on blood pressure and emotional health in hypertensive employees. Altern Complement Med 2003; 9: 355-369.
28. Ames SC, Jones GN, Howe JT, Brantley PJ. A prospective study of the impact of stress on quality of life: An investigation of low-income individuals with hypertension. Ann Behav Med 2001; 23: 112-119.
29. Fallo F, Barzon L, Rabbia F, Navarrini C, Conterno A, Veglio F et al. Circadian blood pressure patterns and life stress. Psychother Psychosom 2002; 71: 350-356.
30. Baune BT, Aljeesh Y. The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip. Ann Gen Psychiatry 2006; 5: 6.
31. MacDonald MB, Sawatzky JE, Wilson TW, Laing GP. Lifestyle profiles of hypertensives. Can J Cardiovas Nurs 1991; 2: 3-8.
32. Stein JD, Brown GC, Brown MM, Sharma S, Hollands H, Stein HD. The Quality of life of patients with hypertension. J Clin Hypertens 2002; 4: 181-188.
33. Lin RY, Trivino MR, Curry A, Pesola GR, Knight RJ, Lee HS et al. Interleukin 6 and C-reactive protein levels in patients with acute allergic reactions: An emergency department-based study. Ann Allergy Asthma Immunol 2001; 87: 412-416.
34. Roca-Cusachs A, Badia X, Dalfo A, Gascon G, Abellan J, Lahoz R et al. Relationship between clinical and therapeutic variables and health related quality of life in patients with hypertension. MINICHAL Study. Med Clin 2003; 121: 12-17.
35. Phillips K. The role of aerobic exercise in blood pressure reduction and quality of life. CANNT J 2005; 15: 60-61.
36. Tsai JC, Yang HY, Wang WH, Hsieh MH, Chen PT, Kao CC et al. The beneficial effect of regular endurance exercise training on blood pressure and quality of life in patients with hypertension. Clin Exp Hypertens 2004; 26: 255-265.
37. Robbins MA, Elias MF, Croog SH, Colton T. Unmedicated blood pressure levels and quality of life in elderly hypertensive women. Psychosom Med 1994; 56: 251-259.